Soretolide

Drug Profile

Soretolide

Alternative Names: D 2916

Latest Information Update: 23 Mar 2007

Price : $50

At a glance

  • Originator Biocodex; University of Washington
  • Class Antiepileptic drugs; Benzamides; Neuroprotectants
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Epilepsy

Most Recent Events

  • 23 Jan 2001 No-Development-Reported for Epilepsy in USA (Unknown route)
  • 23 Jan 2001 No-Development-Reported for Epilepsy in France (Unknown route)
  • 15 Jan 1998 D 2916 is now called soretolide
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top